Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Ming-Hsiang Lee
Introduction
Ming-Hsiang Lee is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of Alzheimer's disease. With a total of 2 patents, his work has the potential to impact the lives of many individuals affected by this condition.
Latest Patents
Ming-Hsiang Lee's latest patents focus on groundbreaking methods for diagnosing and treating Alzheimer's disease. The first patent describes methods for identifying and measuring one or more non-classical variants of the amyloid precursor protein (APP) gene. This innovation provides methods for diagnosing and treating individuals who are suspected of having Alzheimer's disease, based on the identification of an expression profile or an activity profile of these variants. The second patent outlines methods for inhibiting the generation of non-classical variants of the APP gene. This patent also includes methods for diagnosing individuals with Alzheimer's disease and treating them using reverse transcriptase inhibitors or their salts.
Career Highlights
Ming-Hsiang Lee is affiliated with the Sanford Burnham Prebys Medical Discovery Institute, where he conducts his research. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.
Collaborations
Ming-Hsiang Lee collaborates with esteemed colleagues such as Jerold Chun and William J. Romanow. These partnerships enhance the research efforts and contribute to the development of effective treatments for Alzheimer's disease.
Conclusion
Ming-Hsiang Lee's contributions to the field of Alzheimer's research are noteworthy and demonstrate his dedication to innovation in medical science. His patents reflect a commitment to improving the diagnosis and treatment of this challenging disease.